Submitted:
16 November 2026
Posted:
18 November 2026
You are already at the latest version
Abstract
Allergic rhinitis (AR) is the most common chronic inflammatory disease of the upper airways and has traditionally been classified as an IgE-mediated inflammatory disorder of the nasal mucosa. However, accumulating evidence indicates that AR is a complex immune-mediated disease associated with type 2 inflammation, driven by interactions among genetic predisposition, environmental exposures, epithelial barrier dysfunction, and impaired immune regulation. Disruption of epithelial integrity promotes the release of alarmins, which initiate innate immune activation and subsequently amplify the adaptive type 2 immune response. Sustained production of IL-4, IL-5, and IL-13 contributes to IgE synthesis, eosinophilic inflammation, and chronic remodeling of the nasal mucosa. Within this immunological framework, local allergic rhinitis (LAR) has emerged as a distinct disease endotype, despite negative results on conventional allergy tests. Concurrently, advances in diagnostic methodologies, including molecular allergy diagnostics, nasal allergen provocation testing, and the assessment of allergen-specific IgE and allergic inflammatory mediators in samples collected directly from the nasal cavity, have enabled the evaluation of immune responses at the target organ level. Increasing emphasis is also being placed on precision medicine based on inflammatory endotypes and treatable traits. The development of biologic therapies targeting IgE, IL-4/IL-13, IL-5, and epithelial-derived cytokines exemplifies the transition from symptom-oriented treatment towards mechanism-based therapeutic strategies. Further integration of molecular diagnostics with targeted immunomodulation is expected to improve disease control and facilitate more individualized management of patients with allergic rhinitis and local allergic rhinitis.
Keywords:
allergic rhinitis
; local allergic rhinitis
; epidemiology
; type 2 inflammation
; epithelial barrier dysfunction
; thymic stromal lymphopoietin
; IL-25
; IL-33
; precision medicine
; diagnostic
; Rhino`POOL
; allergen immunotherapy
; biomarkers
; endotypes
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.